- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
FDA tightens its grip on handheld ultrasound
The FDA has denied a request for over-the-counter sales of handheld Doppler fetoscopes.
The FDA has denied a request for over-the-counter sales of handheld Doppler fetoscopes. The American College of Radiology and the American Institute of Ultrasound in Medicine, which have aggressively lobbied to stop unwarranted use of ultrasound technology by nonmedical personnel, hailed the decision.
"Patients should understand that ultrasound is very useful, but it needs to be done only when medically necessary. People have to avoid its use for entertainment purposes," said Dr. Carol Rumack, head of the ACR's ultrasound commission.
The FDA's move comes on the heels of a study published by Yale University researchers, who found that exposing pregnant mice to high-frequency ultrasound for 30 minutes or more could result in fetal brain damage.
Can Intestinal Ultrasound Provide an Alternative for Evaluating Creeping Fat with Crohn’s Disease?
September 25th 2024Intestinal ultrasound demonstrated an 88.2 percent agreement with computed tomography enterography in characterizing creeping fat in patients with Crohn’s disease, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
FDA Clears Controlled Contrast Delivery Method for Ultrasound Imaging of Fallopian Tubes
September 9th 2024Facilitating natural contrast delivery through an intrauterine catheter, FemChec can be utilized for ultrasound assessment of fallopian tubes and may provide diagnostic confirmation for an emerging non-surgical option for permanent birth control.
